Bridger Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-56,053
| Closed | -$35M | – | 39 |
|
|
2020
Q2 | $35M | Sell |
56,053
-35,744
| -39% | -$22.3M | 3.24% | 16 |
|
|
2020
Q1 | $44.8M | Buy |
+91,797
| New | +$44.8M | 5.19% | 5 |
|
|
2017
Q3 | – | Sell |
-51,505
| Closed | -$25.3M | – | 37 |
|
|
2017
Q2 | $25.3M | Buy |
+51,505
| New | +$25.3M | 1.44% | 29 |
|
|
2015
Q3 | – | Sell |
-54,132
| Closed | -$27.6M | – | 45 |
|
|
2015
Q2 | $27.6M | Buy |
+54,132
| New | +$27.6M | 0.87% | 31 |
|
|
2014
Q4 | – | Sell |
-16,218
| Closed | -$5.85M | – | 45 |
|
|
2014
Q3 | $5.85M | Buy |
+16,218
| New | +$5.85M | 0.4% | 39 |
|
|
2014
Q2 | – | Sell |
-55,000
| Closed | -$16.5M | – | 45 |
|
|
2014
Q1 | $16.5M | Buy |
+55,000
| New | +$16.5M | 1.1% | 34 |
|